Related Experiment Video
Updated: Jul 6, 2026
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
[Effect of FTY720 on glomerulosclerosis and expression of cell cycle regulatory proteins in subtotally nephrectomized
Guo-qin Zhu1, Jian-hua Zhou, Min Xie
1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Objective:
To study the effect of FTY720 on glomerulosclerosis and expression of cell cycle regulatory proteins in subtotal nephrectomized rats.
Methods:
Twenty-four rats were divided into sham-operation group, glomerulosclerosis model group and FTY720 treated glomerulosclerosis group with 8 rats in each group. The rats in the latter two groups were subjected to subtotal nephrectomy. After operation, the FTY720 treated group was fed with FTY720 at a dose of 0.5 mg/(kg x d) for 12 weeks. Urine protein excretion was measured before operation and 2 w, 4 w, 8 w and 12 w after operation. Then the rats were sacrificed and the left kidney was subjected to pathological evaluation. The expression of collagen IV, fibronectin, and cyclin E, p21, p27 were determined by immunohistochemical methods.
Results:
Compared with the control group, the model group showed higher daily urine protein (Up) excretion from 2 w, (8.07 +/- 1.61) mg/d and thereafter. At 12 w, Up increased to (28.60 +/- 12.21) mg/d in model group, significantly higher than that in control group (P < 0.05). After treatment with FTY720, Up began to decrease from 4 w after operation, (9.90 +/- 1.49) mg/d at that time and (11.35 +/- 2.09) mg/d at 12 w, both were significantly lower than those in model group (P < 0.01). The model group showed higher level of serum creatinine from 8 w, (61.08 +/- 4.28) micromol/L at that time, (130.20 +/- 23.90) micromol/L at 12 w, both were much higher than those in control group (P < 0.05). In FTY720 treated group, serum creatinine level was (80.19 +/- 7.11) micromol/L at 12 w, much lower than that in model group. The changes of BUN were similar to those of creatinine in each group. Renal pathology and immunohistological evaluation showed that FTY720 could significantly inhibit the expression of collagen-IV and fibronectin in glomeruli and attenuate the extent of glomerulosclerosis. Moreover, FTY720 could upregulate glomerular expression of p21 and downregulate glomerular expression of p27 and cyclin E. The expression levels of p21 and cyclin E were significantly lower in treatment group than in model group (P < 0.05), but still higher than those in control group (P < 0.05). p27 expression in glomeruli was stronger in treatment group than that in model group (P < 0.05), and lower than that in normal group but the difference was not significant.
Conclusion:
FTY720 can diminish urine protein excretion and prevent glomerulosclerosis in subtotally nephrectomized rats. This protective effect is presumed to be associated with its effect on expression of cell cycle regulatory proteins, and inhibition of extracellular matrix accumulation in glomeruli.
Insights
FTY720 treatment reduced urine protein and prevented glomerulosclerosis in rats with reduced kidney mass. This protective effect is linked to modulating cell cycle proteins and inhibiting extracellular matrix buildup in the glomeruli.
Area of Science:
- Nephrology
- Pharmacology
- Cell Biology
Context:
- Glomerulosclerosis is a major cause of chronic kidney disease.
- Subtotal nephrectomy in rats is a model for studying progressive renal injury.
- Cell cycle dysregulation is implicated in the pathogenesis of glomerulosclerosis.
Purpose:
- To investigate the therapeutic potential of FTY720 in a rat model of glomerulosclerosis.
- To examine the effects of FTY720 on renal function markers, including urine protein and serum creatinine.
- To evaluate the impact of FTY720 on the expression of key cell cycle regulatory proteins (p21, p27, cyclin E) and extracellular matrix components (collagen IV, fibronectin) in the glomeruli.
Summary:
- Subtotal nephrectomy led to increased urine protein excretion, elevated serum creatinine, and glomerulosclerosis.
- FTY720 treatment significantly reduced urine protein excretion and serum creatinine levels compared to the untreated model group.
- FTY720 administration attenuated glomerulosclerosis, inhibited collagen IV and fibronectin deposition, and modulated the expression of p21, p27, and cyclin E in the glomeruli.
Impact:
- FTY720 demonstrates renoprotective effects in a rat model of kidney injury.
- The findings suggest that FTY720 may be a potential therapeutic agent for glomerulosclerosis.
- Modulation of cell cycle proteins and extracellular matrix accumulation are key mechanisms underlying FTY720's protective action.
More Related Videos
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013